News

SME-owners daily rate update for HORIZON

Published on | 6 months ago

Programmes
Horizon Europe HorizonEU L+F

The personnel cost of SME owners and natural persons beneficiaries has to be declared by using the unit cost (daily rate) fixed by the authorisation decision C(2020)7155 and set out in Annex 2a, as explained in the Annotated Model Grant Agreement p 64.

This Annex 2a has been updated again in December, stating the following SME owner unit cost expressed as daily rates:

  • For calls with opening date before 30 July 2024: {EUR 5 080 / 18 days = 282,22} multiplied by{country-specific correction coefficient of the country where the beneficiary is established}
  • For calls with opening date as from 30 July 2024: {EUR 8 745,40 / 18 days = 485,85} multiplied by {country-specific  orrection coefficient of the country where the beneficiary is established}
  • For calls with opening date as from 16 December 2025: {EUR 9271 / 18 days = 515,06} multiplied by {country-specific correction coefficient of the country where the beneficiary is established}

The country-specific correction coefficients used are those set out in the Horizon Europe Work Programme
(section Marie Skłodowska-Curie actions) in force at the time of the call (see Portal Reference Documents). For Belgium this coefficient equals 1.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1972 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.